Phase2Phase Biopharma

Phase2Phase Biopharma, founded in 2017, is a Nordic Life Science Firm consisting of three business units, together promoting the development of new and better therapies for the benefit of patients and society.

Phase2Phase Biopharma Consulting provides senior competence and services within CMC (Chemistry, Manufacturing & Control), Quality Assurance and thereto related services. Phase2Phase frequently supports its clients with CDMO Sourcing, Contract Negotiation, Due Diligence, CMC Strategies, Technology Transfer and Project Management.

Phase2Phase Biopharma Manufacturing will provide GMP Drug Substance Manufacturing for biopharmaceutical companies at both clinical and commercial stage.

Phase2Phase Biopharma Ventures focuses on seed investments in early-stage life science projects. The most ideal projects are companies developing biopharmaceuticals but also companies inventing new technologies, supporting the innovation and development of new medicines.